Related Experiment Video
Updated: Jun 25, 2026
04:41
Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
[Therapeutic advances in neurology]
J Morier1, R Du Pasquier, T Kuntzer
1Service de neurologie, CHUV, Lausanne. julien.morier@chuv.ch
Revue Medicale Suisse
|February 17, 2009
Summary
Neurology saw major advances in 2008, including extended stroke treatment windows and new therapies for Parkinson's disease, multiple sclerosis, and epilepsy. Promising treatments for migraine and amyotrophic lateral sclerosis were also highlighted.
Area of Science:
- Neurology
- Neuroscience
- Pharmacology
Context:
- 2008 advancements in neurological treatments.
- Focus on acute ischemic stroke, Parkinson's disease, multiple sclerosis, epilepsy, migraine, and amyotrophic lateral sclerosis.
- Emerging therapeutic strategies and pharmacological developments.
Purpose:
- To summarize key 2008 breakthroughs in neurology.
- To highlight new treatment options and research findings.
- To provide an overview of advancements across various neurological conditions.
Summary:
- Intravenous thrombolysis window extended to 4.5 hours for acute ischemic stroke.
- Potential disease-slowing medications and early deep brain stimulation for Parkinson's disease.
- New treatments like Tysabri and Fingolimod for multiple sclerosis; developing epilepsy pharmacopoeia.
- CGRP receptor antagonists show promise for acute migraine; improved pharmacological approaches for amyotrophic lateral sclerosis.
Impact:
- Significant improvements in managing acute ischemic stroke.
- Potential to alter the course of Parkinson's disease progression.
- Expanded therapeutic options for multiple sclerosis and epilepsy patients.
- New avenues for acute migraine and amyotrophic lateral sclerosis treatment.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:01Neuroplasticity
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications